NUTRITION 21 REPORTS DIACHROME DATA

A A

Nutrition 21 has reported results from a new clinical trial that shows long-term daily supplementation with Diachrome, a proprietary combination of chromium picolinate and biotin, can significantly improve blood sugar levels in people with Type 2 diabetes who had poorly controlled blood sugar levels and were taking prescription antidiabetic medications.

The results, which evaluated 28 people over nine months, were presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions in Washington D.C.

The new data come from an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multicenter study that evaluated 368 subjects taking daily Diachrome supplementation and showed a 0.53% average drop in HbA1c. The long-term study provided a further average decrease of 0.96 percent HbA1c. Ten of the 24 subjects who completed the nine-month study, or 42 percent, reached the American Diabetes Association's target HbA1c level of less than 7 percent.